Scholarlink

Background <p>Endometrial polyps are common, localized overgrowths of endometrial glands and stroma that protrude into the uterine cavity. These tumor-like lesions can cause symptoms like abnormal uterine bleeding and infertility, and they may undergo malignant transformation. The etiology of endometrial polyps remains largely unknown.</p> Methods <p>Here, we conducted whole-genome sequencing and global gene expression profiling on 23 polyps. Major findings were validated with targeted DNA (Sanger sequencing) and protein (immunohistochemistry) level analyses. Sanger sequencing was also utilized to validate the observed novel alterations in an additional set of 54 polyp samples.</p> Results <p>The most common alterations were chromosomal rearrangements affecting <i>HMGA1</i> and <i>HMGA2</i>, identified in 74% (17/23) of the polyps. These rearrangements involved <i>LRMDA</i>, <i>RAD51B</i>, <i>TRAF3IP2</i>, and 7p15.2 as recurrent rearrangement partners. 3′RNA sequencing indicated corresponding overexpression of <i>HMGA1</i> and <i>HMGA2</i> as well as a downstream target <i>PLAG1</i>. Elevated protein level expression of HMGA1 and HMGA2 was further shown using immunohistochemistry. In addition to frequent <i>HMGA1</i> and <i>HMGA2</i> alterations, we found <i>UBE2A</i> as a novel candidate driver gene with highly specific recurrent mutations. We also identified recurrent low-allelic fraction mutations in well-established cancer genes <i>KRAS</i>, <i>PIK3CA</i>, <i>PIK3R1</i>, and <i>PTEN</i>.</p> Conclusions <p>Here, we have characterized the genomic landscape of endometrial polyps. We show that chromosomal alterations affecting <i>HMGA1</i> and <i>HMGA2</i> are a major underlying cause for polyp development. In addition, we present <i>UBE2A</i> as a novel candidate gene for human tumorigenesis. Our results contribute to a better understanding of endometrial polyp development and pave the way towards the development of targeted, non-invasive treatment options.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic landscape of endometrial polyps

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月24日

查看全文
  • Siiri Reinikka,
  • Miika Mehine,
  • Pernilla von Nandelstadh,
  • Terhi Ahvenainen,
  • Sara Khamaiseh,
  • Susanna Nousiainen,
  • Vilja Jokinen,
  • Annukka Pasanen,
  • Ralf Bützow,
  • Nanna Sarvilinna,
  • Esa Pitkänen,
  • Pia Vahteristo

摘要

Background

Endometrial polyps are common, localized overgrowths of endometrial glands and stroma that protrude into the uterine cavity. These tumor-like lesions can cause symptoms like abnormal uterine bleeding and infertility, and they may undergo malignant transformation. The etiology of endometrial polyps remains largely unknown.

Methods

Here, we conducted whole-genome sequencing and global gene expression profiling on 23 polyps. Major findings were validated with targeted DNA (Sanger sequencing) and protein (immunohistochemistry) level analyses. Sanger sequencing was also utilized to validate the observed novel alterations in an additional set of 54 polyp samples.

Results

The most common alterations were chromosomal rearrangements affecting HMGA1 and HMGA2, identified in 74% (17/23) of the polyps. These rearrangements involved LRMDA, RAD51B, TRAF3IP2, and 7p15.2 as recurrent rearrangement partners. 3′RNA sequencing indicated corresponding overexpression of HMGA1 and HMGA2 as well as a downstream target PLAG1. Elevated protein level expression of HMGA1 and HMGA2 was further shown using immunohistochemistry. In addition to frequent HMGA1 and HMGA2 alterations, we found UBE2A as a novel candidate driver gene with highly specific recurrent mutations. We also identified recurrent low-allelic fraction mutations in well-established cancer genes KRAS, PIK3CA, PIK3R1, and PTEN.

Conclusions

Here, we have characterized the genomic landscape of endometrial polyps. We show that chromosomal alterations affecting HMGA1 and HMGA2 are a major underlying cause for polyp development. In addition, we present UBE2A as a novel candidate gene for human tumorigenesis. Our results contribute to a better understanding of endometrial polyp development and pave the way towards the development of targeted, non-invasive treatment options.